H-Index
34
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Get your full text copy in PDF

From the Guest Editor

Waldemar L Olszewski

Ann Transplant 2006; 11(4): 15-15

ID: 497028


Most attention of the transplatologists is directed at the immune events after allogeneic grafting mediated by the MHC complex and the executors as antigenpresenting cells (APC) and lymphocytes. This is quite understandable as down-regulation of their specific activity against the graft MHC products using the immunosuppressive agents prevents rejection.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree